The FDA approved a new once-daily Parkinson’s pill in the dopamine agonist class, designed to selectively target receptors studied for decades; in trials, AbbVie’s drug improved movement and daily functioning | Read More in ynet – Culture
UAE confirms Netanyahu visit, discussion over bilateral relations with MBZ via state news agencyDutch man arrested in ShinyHunters investigation alleged to have been ‘reformed hacker’Pools, marble and mansions: Inside 100 Palestinian luxury homes in West BankTrump vows victory in Iran war ‘very soon,’ officials in talks with Iranian mediators
UAE confirms Netanyahu visit but omits denial of reported pre-Oct. 7 warning call
‘We will not let you succeed’: UK foreign secretary lashes out at Netanyahu government
New details reveal how Israel protected Hezbollah pager operation after suspicions emerged
IDF braces for Hamas kidnapping attempt along Gaza’s Yellow Line
‘You should join the dots’: TV host erupts at UK defense chief after suspected terror plot
Pager plot: Israel’s secret moves to keep Hezbollah in the dark
The First Call of “Dor’s Ambulance”
Smotrich’s response to the Palestinian AuthorityUAE confirms Netanyahu visit, discussion over bilateral relations with MBZ via state news agencyDutch man arrested in ShinyHunters investigation alleged to have been ‘reformed hacker’Pools, marble and mansions: Inside 100 Palestinian luxury homes in West BankLebanese PM meets Rubio, stresses need for IDF withdrawal, Hezbollah disarmamentTrump vows victory in Iran war ‘very soon,’ officials in talks with Iranian mediators